We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current MX1 market cap is 48.25M. The company's latest EPS is AUD -0.0207 and P/E is -4.35.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 5.3M | 7.55M | 6.78M | 13.09M | 22.33M |
| Operating Income | -10.11M | -9.22M | -14.06M | -16.81M | -10.55M |
| Net Income | -9.83M | -10.07M | -14.73M | -17.09M | -10.75M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 9.87M | 33.7M | 44.68M | 31.28M | 30.3M |
| Total Liabilities | 12.85M | 18.8M | 10.47M | 11.99M | 13.11M |
| Total Equity | -2.98M | 14.9M | 34.21M | 19.29M | 17.19M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -7.15M | -9.46M | -9.86M | -18.11M | -10.99M |
| Investing | -1.71M | -2.2M | -901k | -1.11M | -779k |
| Financing | 6.4M | 28.37M | 22.58M | -612k | 6.69M |
| Market Cap | 48.25M |
| Price to Earnings Ratio | -4.35 |
| Price to Sales Ratio | 2.09 |
| Price to Cash Ratio | 8.91 |
| Price to Book Ratio | 2.72 |
| Dividend Yield | - |
| Shares Outstanding | 518.82M |
| Average Volume (1 week) | 1M |
| Average Volume (1 Month) | 484.64k |
| 52 Week Change | -2.11% |
| 52 Week High | 0.16 |
| 52 Week Low | 0.085 |
| Spread (Intraday) | 0 (3.19%) |
| Company Name | Micro X Limited |
| Address |
a14 adelaide, south australia 5042 |
| Website | https://www.micro-x.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
